key: cord-0315961-du0vkvl8
authors: Nourbakhsh, S.; Fazil, A.; Li, M.; Mangat, C. S.; Peterson, S. W.; Daigle, J.; Langner, S.; Shurgold, J.; D'Aoust, P. M.; Delatolla, R.; Mercier, E.; Pang, X.-L.; Lee, B. E.; Stuart, R.; Wijayasri, S.; CHAMPREDON, D.
title: A Wastewater-Based Epidemic Model for SARS-CoV-2 with Application to Three Canadian Cities
date: 2021-07-25
journal: nan
DOI: 10.1101/2021.07.19.21260773
sha: ebd993db9df42641c1ab2f5dfc73f99476824092
doc_id: 315961
cord_uid: du0vkvl8

The COVID-19 pandemic has stimulated wastewater-based surveillance, allowing public health to track the epidemic by monitoring the concentration of the genetic fingerprints of SARS-CoV-2 shed in wastewater by infected individuals. Wastewater-based surveillance for COVID-19 is still in its infancy. In particular, the quantitative link between clinical cases observed through traditional surveillance and the signals from viral concentrations in wastewater is still developing and hampers interpretation of the data and actionable public-health decisions. We present a modelling framework that includes both SARS-CoV-2 transmission at the population level and the fate of SARS-CoV-2 RNA particles in the sewage system after faecal shedding by infected persons in the population. Using our mechanistic representation of the combined clinical/wastewater system, we perform exploratory simulations to quantify the effect of surveillance effectiveness, public-health interventions and vaccination on the discordance between clinical and wastewater signals. We also apply our model to surveillance data from three Canadian cities to provide wastewater-informed estimates for the actual prevalence, the effective reproduction number and incidence forecasts. We find that wastewater-based surveillance, paired with this model, can complement clinical surveillance by supporting the estimation of key epidemiological metrics and hence better triangulate the state of an epidemic using this alternative data source.

infected, susceptible individuals enter the latent (non-infectious) state (E) for an average duration of 1/ days, where no faecal shedding occurs. A proportion α of all infections are 122 asymptomatic. A fraction h of symptomatic individuals are hospitalized (H) for an average duration of 1/ days and for those, the COVID-19-associatied mortality is δ. After their in-124 fectious period ends, patients enter the post-infection shedding state Z where SARS-CoV-2 faecal shedding still occurs for 1/η days on average. The exposed (E), infectious (A, I and 126 J) and post-infection shedding (Z) states are modelled with a series of sub-compartments in order to have their respective sojourn time gamma-distributed [43, 44, 45] . Note that in 128 our model, we make the simplifying assumption that hospitalized patients-assumed mostly bedridden and a small fraction of the shedding population-do not contribute significantly 

I k = n I ν(I k−1 − I k ) 2 ≤ k ≤ n I (1g)

where A = ξ n A k=1 φ k A k , I = n I k=1 ψ k I k and J = n J k=1 ψ k J k . We use the dot notation to symbolize derivation with respect to time (e.g.,Ṡ = dS/dt). The parameters φ and ψ are multiplicative adjustments to the baseline transmission rate β t to represent the infectious profile during the course of infection. The values for φ k and 138 ψ k were chosen to represent the best estimate of the temporal infectiousness profile given the different results published (see Appendix, Figure S2 ). The parameter ξ models the 140 relative infectiousness of asymptomatic cases compared to symptomatic ones. The effective reproduction number of this model is (see Appendix for details on its calculation):

The daily concentration of SARS-CoV-2 in wastewater is directly calculated from the total number of individuals that are actively shedding into the sewage system. SARS-CoV-2 146 faecal shedding varies according to the infected individual's clinical state and disease outcomes. Depending on the disease progression, infected individuals shed a variable amount of SARS-CoV-2 while they are in the shedding states (A, I, J and Z ). The total concentration of SARS-CoV-2 RNA entering the wastewater at time t is given by

The parameters λ k , λ A k and λ Z k represent SARS-CoV-2 faecal shedding dynamics per capita when the infected individual is in the epidemiological states I, J, A and Z respectively. 152 Given the current lack of observational data, we used the same parameters λ k for all epidemiological states (i.e., λ k = λ A k = λ Z k ). Values for the parameters λ k were chosen 154 to represent mid-range values of the different results published (see Appendix Figure S2 ). Note that we assume the same reduction in faecal shedding as in respiratory shedding for 156 asymptomatic cases (parameter ξ). The parameter ω implies that our model can only determine up to a constant the concentration of SARS-CoV-2 in wastewater [14] , even if 158 the limit of detection of the assay is known. This reflects our current inability to quantify the various complex processes that affect the concentration, from patients' shedding to 160 the concentration measured in laboratories (e.g., frequency and timing of sampling, RNA degradation in the sewer system, recovery efficiency of assays). 

We use a simple advection-dispersion-decay model to simulate the fate of SARS-CoV-2 164 along its journey in wastewater from the shedding points to the sampling site. This model is a combination of an exponential viral decay [46] and a τ -day dispersed plug-flow function, 166 g(τ ), representing all possible hydrodynamic processes (e.g., dilution, sedimentation and resuspension) that leads to RNA degradation as well as decrease and delay of signal at the 168 time of sampling. The dispersed plug-flow g(τ ) acts as a transformation function, which reshapes the initial deposited concentration, W * , into a delayed viral distribution over τ 170 days as a result of the transit of SARS-CoV-2 in the sewer system. Hence, we defined the sampled viral concentration at time t as:

where κ is the daily decay rate of SARS-CoV-2 due to the harsh, complex and bioactive environment of wastewater [46] . The SARS-CoV-2 RNA concentration entering the sewage 174 system daily is modelled as a single hydrodynamic pulse per day and the plug-flow function, g, is obtained by the analytical solution of the axial dispersed plug flow differential 176 equation [47] . We then re-parametrize the analytical solution with the mean delay timeτ and its standard deviation σ into a Gaussian distribution 

where ww is the reporting lag between wastewater sampling and concentration report after laboratory analysis. (Note that the reporting delay of the wastewater measurement is 186 independent from the delay caused by the transport of RNA particles in the sewer system as defined in Equation 4).

We also model surveillance data derived from laboratory confirmed and clinically diagnosed 190 COVID-19 cases, acknowledging that instantaneous identification and complete reporting after initial infection is not possible. We assume that a fraction ρ of symptomatic incidence 192 is reported with a lag of a clinical days from the time of infection. If i(t) is the total incidence at time t, we define the number of clinical cases reported at time t as:

194

We apply our modelling framework to data sets from six wastewater sampling sites located 196 in three Canadian cities: Edmonton (Alberta), Ottawa (Ontario) and Toronto (Ontario Scientific, Ottawa, ON) using 4 × 30s pulses at 6 m/s, then clarified by centrifugation (12000 × g, 3 min) and the resultant lysate used for RNA extraction using the MagNA 222 Pure 96 instrument as described above. Viral RNA was quantified using RTq-PCR with the US-CDC N1 and N2 primers.

For Ottawa, daily 24-hour composite primary sludge samples, consisting of four discrete samples collected at 6 hour intervals and subsequently mixed, were collected and trans-226 ported on ice to the University of Ottawa, where samples were analyzed within 24 hours of reception. Samples were concentrated by centrifugation at 10,000g for 45 minutes and 228 RNA was extracted from a 250 mg portion of the resulting pellet using a modified version of the Qiagen RNeasy PowerMicrobiome kit [28] . Quantification was performed using 230 singleplex probe-based RTq-PCR for the N1 and N2 gene regions of the virus.

For Edmonton and Toronto, the SARS-CoV-2 concentrations in wastewater were normal-232 ized by the total solid suspension (TSS) measured on the day the sample was collected at the treatment plant. For Ottawa, they were normalized with the concentration of the 234 Pepper mild mottle virus measured in the sample. For all cities, the reported viral concentration used in the model (W ) was the average normalized concentration across all 236 technical replicates for both the N1 and N2 genes.

We obtained clinical cases and hospital admissions (except for Toronto) for the catchment 238 area of each of the six wastewater treatment plants. Hence, we were able to link clinical and wastewater surveillances. The data sets for the three cities are plotted in Figure 2 240 Seroprevalence values at the city and province level were obtained from Canadian Blood Services (CBS) [53] . The wastewater and clinical surveillance data used in this study are 242 available in Supplementary File S1. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 25, 2021. 

We use 50, 000 prior ABC iterations and retain the 100 smallest errors to generate posterior 248 distributions (acceptance ratio 2 × 10 −3 ). The parameters fitted are the time-dependent transmission rate β t , ω, the hospitalization rate h and the mean transit timeτ . More 250 details about the fitting procedure is given in Appendix.

We define three types of fitting-to-data procedures. "Clinical" when w C = w H = 1 and 252 w W = 0, to use data from clinical sources only ; "WW" when w W = 1 and w H = w C = 0, to use wastewater data only; and finally "Combined" by choosing the weights w C , w H and 

The posterior cumulative incidence is obtained by summing Equation 1a until time t 264

The fitted model can also provide an estimate of the effective reproduction number from the different data sources (e.g., clinical and/or wastewater) using Equation 2. 

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 25, 2021. ; https://doi.org/10.1101/2021.07.19.21260773 doi: medRxiv preprint d ww and defined as W (t = d ww ) = LOD where LOD is the limit of detection of the laboratory method. In addition, the time d clinical when COVID-19 is first reported is defined as 272 C(t = d clinical ) = 1. Finally, we define the reported detection differential ∆ = d ww − d clinical . As a result, the wastewater signal can be classified as a leading indicator over traditional 274 clinical surveillance when ∆ < 0. We assess how the reported detection differential ∆ can be impacted by varying model parameters that would typically differ from one community-276 sewer system to another. We select only three combinations of parameters (among many) to illustrate how ∆ can be affected, and most importantly how its sign can change indi-278 cating its transition between a leading and lagging indicator. We consider two levels of COVID-19 reporting, with ρ = 30% to reflect a relatively inefficient clinical surveillance 280 system in the population, and ρ = 70% that represents a more efficient one.

Although the model presented here does not explicitly have a vaccination process, a mechanism using the existing framework can be implemented to mimic the main effects of an 284 infection-permissive vaccine (as this is the case for the COVID-19 vaccines currently available). We model a simple scenario that rolls out an infection permissive vaccine by gradu-286 ally decreasing the transmission rate (β) by 70% over 50 days and increasing the proportion of asymptomatic infection (α) from 30% to 90%. This reflects the growing protection of 288 the population from severe outcomes of COVID-19 as well as decrease in transmissions as the vaccine is administered. To assess the differential impact of vaccination on clinical and 290 wastewater observations, we consider the ratio of the level of SARS-CoV-2 in wastewater over the reported clinical cases, W (t)/C(t).

We present our results in two sections. First, we apply our modelling framework to wastew-294 ater and clinical surveillance data from six sampling sites located in three Canadian cities (Edmonton, Ottawa and Toronto) and infer epidemiological parameters such as prevalence, 296 effective reproduction number and incidence forecast. The second section is based on exploratory simulations (not fitted to data of a specific location) that highlight important 298 mechanistic aspects between clinical and wastewater surveillances.

In this section, we compare the inferences made on key epidemiological variables by fitting the model to different data sources. Our goal is to assess the added-value of the wastewater-302 based data stream. Hence, in the following, we present inferences by fitting the model to different data sources available ("Clinical", "WW" and "Combined") and comparing the 304 outcomes.

saved on 2021-07-19 15:54:19-04:00

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 25, 2021. ; https://doi.org/10.1101/2021.07.19.21260773 doi: medRxiv preprint Figure 3 shows, for selected locations, the SARS-CoV-2 prevalence estimated by sampling the posterior distributions fitted to the various data sources "Clinical", "WW" and "Com-308 bined" and the evaluation of Equation 9 . The right-most panel also displays estimates of cumulative incidence (Equation 10) compared to available SARS-CoV-2 seroprevalence lev-310 els estimated from surveys by the Canadian Blood Services performed on banks of blood donors in Edmonton, Ottawa and Toronto [53] . Note that our model was not fitted to Finally, we note that, because of the larger variability of SARS-CoV-2 WBS and/or their lower sampling frequency as compared to daily clinical surveillance, credible intervals of our 326 wastewater-only inferences are generally larger than the clinical-only ones ( Figure 3 ).

The effective reproduction number (R t ) is a key epidemiological parameter that has gained recognition and application during the COVID-19 pandemic [55, 56]. Using the same ap-330 proach as for prevalence estimates, we inferred R t from epidemic trajectories generated from posterior distributions fitted to the three different data sources (i.e., "Clinical", 332 "WW" and "Combined") and Equation 2. For comparison, we also calculate R t using the popular R package EpiEstim (version 2.2) [57] from the reported clinical cases as 

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 25, 2021. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 25, 2021. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 

Another key advancement in our modelling framework is to generate forecasts based on clinical, hospital (if available) and wastewater data. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 25, 2021. 

In this section, we report results from simulations that provide general insights in inter-362 preting WBS.

4.2.1 Leading signal and reported detection differential 364 We vary the LOD of the wastewater assay across a broad, but realistic, range [58] and calculate ∆, the detection time difference, for each simulation for a given value of LOD 366 and the clinical reporting rate ρ. Because SARS-CoV-2 RNA concentration in wastewater can only be determined up to a constant in our model, the LOD values chosen here are 368 rescaled to the parameters used to run our simulations and cannot be directly interpreted as RNA copies per ml, the traditional unit for LOD. Panel A in Figure 6 shows that, 370 depending on the LOD of the laboratory assay, the wastewater concentration of SARS-CoV-2 RNA can either be a leading (∆ < 0 for assays with low LODs) or a trailing 372 indicator of cases (re)introduction when compared to reported clinical cases. This is the case whether the clinical surveillance system in the population is efficient or not (coloured 374 curves, Figure 6A ).

We also vary the decay rate of RNA SARS-CoV-2 in wastewater within a broad realistic 376 range [46, 59, 60] , as well as the transit time of SARS-CoV-2 between the shedding and sampling sites. Figure 6B shows that , here again, the relative timing of (re)introduction 378 detection by WBS compared to clinical surveillance can be affected by both the harshness of the wastewater (represented by the decay rate) and the transit time of SARS-CoV-2 in 380 the sewer system. We note, as expected, that with a fast transit time (illustrated by a 1day travel time in the left-most panel of Figure 6 ) the decay rate will not have a significant 382 impact on ∆ clinical surveillance (efficient, ρ = 70%, or not, ρ = 30%), but as the transit time increases to 3 days (an upper bound considering strong sediment and recirculation 384 effects) the effect of RNA decay becomes more important (increasing slope for the 1-day and 3-day transit times, Figure 6B ). 

The ability to use wastewater signal to detect intervention effectiveness can also be explored 388 using model simulations in order to explore if a public health intervention is more clearly observable in wastewater concentration measurements or in clinical reports. To do this, 390 we choose to model an intervention such that the transmission rate β, constant until the intervention time, decreases linearly to a lower value β/3 during a period of time of 392 T interv and remains constant afterwards (this aims to crudely simulate a lockdown). We consider the relative difference between the observed peak and 7 days later for COVID- signal.

Using our baseline parameters (Table 2) , we simulate an intervention that reduces the 398 contact rate to a third of its pre-intervention value at different time of the simulations, ranging from 20 to 90 days after the introduction of the index case. Figure 7 shows 400 that, overall, the effect of an intervention that significantly reduces transmission yields a larger relative decrease in number of COVID-19 cases than the level of SARS-CoV-2 in 402 wastewater because the post-peak slope from clinical surveillance (s cl ) is consistently more negative than the one from WBS (s ww ). The difference is more pronounced as the change 404 in transmission is more sudden (T interv small). Hence, given the observation noise typically encountered, we expect that the effect of a sudden change in transmission rate would be 406 more clearly observable from clinical surveillance than from WBS.

In Figure 8 shows how W (t)/C(t), the ratio of reported wastewater concentration over reported cases, increases following vaccination with a infection-permissive vaccine. Indeed, 

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 25, 2021. ; https://doi.org/10.1101/2021.07.19.21260773 doi: medRxiv preprint shedding is less affected by this reporting bias and level of SARS-CoV-2 in wastewater 414 decreases less steadily than COVID-19 surveillance. In this simulation, the approximately constant ratio before the start of vaccination ( Figure 8B ) indicates that reports from clin-416 ical or wastewater data sources provide a similar picture of the epidemic for that period. However, once vaccination is implemented, the increasing ratio highlights a discordance 418 between the two data sources.

Surveillance through detection and quantification of targeted pathogens in wastewater has been a noteworthy tool for public health across the world [61, 16, 18, 10, 11, 12, 13, 14] . Importantly, we observed that estimates based on wastewater-only data usually provide a 436 similar picture of the epidemic trajectory ( Figure 3 ) but discordant signals can occur and lead to drastically different interpretations. This was the case, for example, in January 438 2021 in Toronto Highland Creek where the wastewater signal did not indicate a resurgence of infections, despite the wave observed from the reported clinical cases. We believe this 440 muted peak in wastewater signal was not caused by a laboratory issue, but rather from undetermined events in this particular sewershed at that specific time that need to be 442 further investigated.

Similarly, the effective reproduction numbers inferred from wastewater data only are consis-444 tent with more traditional methods, such as using clinical reports with the popular software EpiEstim (Figure 4) . The fact that wastewater data can potentially act as a substitute 446 for clinical surveillance (albeit with more uncertainty) to provide critical epidemiological metrics is encouraging, although more realistically, it will likely act as a complementary 448 data source. The ability to estimate epidemiological metrics using wastewater surveillance represents a step forward in demonstrating the use of wastewater data for actionable pub- 

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 25, 2021. ; https://doi.org/10.1101/2021.07.19.21260773 doi: medRxiv preprint lic health metrics, if they are available to public health in a timely manner. In addition, the ability to triangulate the state of an epidemic using alternative data sources helps en-452 sure additional confidence in the estimation of relevant parameters or forecasting. Indeed, the COVID-19 pandemic has consumed public-health resources at levels that are probably 454 not sustainable for long-term surveillance of this pathogen. However, the current wastewater surveillance performed in many communities can probably be continued as long as 456 necessary given its relative low cost [9] .

Our modelling framework provides a more principled alternative to simpler smoothing tech-458 niques (e.g., moving averages, polynomial interpolations) that have been used to support the interpretation of WBS [28] . However, we note that less complex modelling options 460 are possible if the focus is on specific epidemiological metrics ([62, 63] ). We also note recent efforts to use machine learning techniques and artificial neural network that incor-462 porate WBS [64] . While those methods are promising, they cannot-by design-explain the epidemiological mechanisms at play.

Our model enables in silico experiments on the epidemic/wastewater system to identify key parameters and processes that can play an important role for the epidemiological inter-466 pretation. We showed, using simulations, that the relative timing of the wastewater signal (whether it is leading or not) compared to traditional clinical surveillance is actually influ-468 enced by the characteristics of both systems ( Figure 6 ). On the one hand, the laboratory analysis of wastewater samples may not detect the presence of SARS-CoV-2 because, for 470 example, its limit of detection is too high, or prevalence of infection in the community is very small, or the viral RNA has degraded before reaching the sampling site. Shipment 472 time of wastewater samples can also be significant (e.g., several days) for remote sampling locations without any laboratory capacity. On the other hand, the delay in clinical cases 474 reports is usually caused by the incubation period and the reporting time of an infection by the health system (turnaround time for contact tracing and/or laboratory results of in-476 dividuals' swab) or availability of testing. Some communities would typically have a longer lag for clinical reporting than for wastewater surveillance [20, 22, 28, 24] , while others may 478 have the opposite (for example when a very effective contact tracing system is in place [65] or rapid testing is implemented). Moreover, a community may experience both situa-480 tions, that is a period when clinical surveillance is extremely efficient at detecting cases so rapidly that it leads wastewater surveillance while, at other times, it can lag (for example 482 when incidence is high, overwhelming contact-tracing and clinical testing capacities). The model presented here allows to quantify how various factors can impacts the relative timing 484 between clinical and wastewater surveillances.

It can be tempting to monitor the effect of public health interventions using changes in the 486 levels of SARS-CoV-2 in wastewater given its non-invasive nature. Indeed, WBS should be less affected by sampling bias than clinical surveillance (for example the latter may is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 25, 2021. ; https://doi.org/10.1101/2021.07.19.21260773 doi: medRxiv preprint surveillance may be inferior to clinical surveillance to identify sharp declines in transmis-490 sion, as typically seen after a lockdown is implemented (Figure 7) . The long period of faecal shedding creates a lag in comparison to the sudden drop of incidence caused by the 492 public health intervention, inhibiting a prompt signal in wastewater. This effect is visible on the Canadian data sets presented here (Figure 2) . 494 We also highlight the potential for an infection-permissive vaccine to generate discordant signals between wastewater and clinical surveillances (Figure 8) . Indeed, vaccination im-496 plies a larger proportion of asymptomatic infections which are less likely to be detected by clinical surveillance, but still picked up in wastewater because of continued faecal shedding.

Note that we use our model to highlight this potential effect, whereas detecting it in real data is probably challenging without studies purposely designed to detect this. 500 Here, we used a mixed approach regarding the normalization of the levels of SARS-CoV-2 in wastewater, with Ottawa using PMMV-normalization versus TSS-normalization for 502 Toronto and Edmonton. It is likely that some normalization is necessary to discount the variations of the total faecal mass shedded and viral degradation, but it is still not clear 504 which normalization is the most appropriate for a given sewershed. We note that we considered separately each WWTP in Toronto to provide examples of application at the 506 sub-municipal level.

Our modelling approach has several weaknesses. We did not precisely model the transport 508 and fate of SARS-CoV-2 in municipal sewer systems. The lack of data about flow dynamics and particles binding of SARS-CoV-2 in wastewater hampered a more detailed approach. 510 Hence, we took a simple approach to model the below-ground component and assumed the flow dynamic followed a low-dispersion plug flow model with a plausible fixed decay rate

[46] and varied the mean transit time (from shedding to sampling sites) within a range of possible values. As more research focuses on the fate of SARS-CoV-2 in wastewater, the 514 transport module of our model can be enhanced. The comparison with observed seroprevalence level must be done with caution, because we 516 do not model seroreversion (patients who were infected but subsequently test seronegative because of loss of immunity or antibodies falling to undetectable levels). Our model does 518 not model vaccination explicitly. We made this choice to keep the first version of our model relatively simple. However, we believe that we can appropriately approximate the 520 effects of infection-permissive vaccination by reducing the transmission rate and increasing the proportion of asymptomatic infections. As the proportion of vaccinated individuals 522 increases, modelling an explicit vaccination process is necessary. We note that for the Canadian cities studied here, the vaccination coverage was either null or low during the 524 study period. We model SARS-CoV-2 as a single-strain pathogen which is an oversimplification of reality, is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 25, 2021. ; https://doi.org/10.1101/2021.07.19.21260773 doi: medRxiv preprint [67, 68] . 530 Because of ordinary differential equations, this model is not well adapted to either small communities or very low prevalence settings. While its epidemiological structure (Figure 1 ) 532 would still be valid for such environments, a more advanced statistical modelling would be preferable to handle low incidence counts and observation uncertainty [69, 70] .

A further limitation of our model is the use of a scaling coefficient for the amount of SARS-CoV-2 shedded in the wastewater by the infected population (parameter ω in Equation 3 ).

This scaling coefficient embeds all the uncertainties associated with sampling strategy and laboratory analysis, such as assay recovery efficiency, limit of detection, and total faecal 538 mass normalization. Most of those processes are currently poorly known for SARS-CoV-2 and, as long as more observational data is not available, will constrain modelling (note 540 that this limitation has already been identified for polio models [14] ). An ultimate goal of wastewater surveillance may be to measure all the components of the scaling coefficient 542 (here, ω) in order to estimate infection prevalence in a community directly from viral concentration readings.

To conclude, the model presented here-built upon previous similar approach for other pathogens [71, 14, 72]-is a first step to better understand the mechanistic relationships 546 between the COVID-19 epidemic spreading in a community and the SARS-CoV-2 RNA concentration in wastewater caused by faecal shedding of infected individuals (and poten-548 tially from urinary or sputum shedding). Future developments should explicitly incorporate vaccination and multiple variants/strains given the ability of new assays to detect variants 550 from wastewater samples [73, 74, 75] . This model can be the basis of quantitative tools to support public health decision making that embraces wastewater-based epidemiology.

Beyond the SARS-CoV-2/COVID-19 pandemic, WBS coupled with the type of model presented here could be leveraged and applied to other transmissible pathogens where urinary 554 or faecal shedding occurs, such as other respiratory diseases (e.g., influenza, respiratory syncytial virus, adenovirus) and some enteric diseases (e.g., norovirus, rotavirus, shigel-556 losis). is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 25, 2021. 

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 25, 2021. ; https://doi.org/10.1101/2021.07.19.21260773 doi: medRxiv preprint Table 1 : Description of the model's compartments and parameters for the SARS-CoV-2 RNA transmission and disease outcome.

Definition S susceptibles E exposed susceptibles but not infectious A k asymptomatic infectious cases in k th subcompartment I k symptomatic infectious cases in k th subcompartment J k symptomatic infectious cases in k th subcompartment who later admits to hospital Z k non-infectious cases but fecal shedding SARS-CoV-2 RNA in k th subcompartment H hospitalized patients R recovered cases D deceased cases β I,k transmission rate in k th subcompartment among symptomatics (per contact) β A,k transmission rate in k th subcompartment among asymptomatics (per contact) 1/ε ave. latency time (days) 1/ν k ave. duration in k th subcompartment among symptomatics (days) 1/µ k ave. duration in k th subcompartment among symptomatics goes to hospital (days) 1/θ k ave. duration in k th subcompartment among asymptomatics (days) 1/η k ave. duration in k th subcompartment of shedding after infectiousness (days) 1/ ave. length of stay in a hospital (days) n I total number of subcompartments in I state n J total number of subcompartments in J state n A total number of subcompartments in A state n Z total number of subcompartments in Z state α proportion of exposed cases that are asymptomatic h proportion of symptomatic cases that need hospital admission δ proportion of deceased individuals among hospitalized patients saved on 2021-07-19 15:54:19-04:00

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 25, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 25, 2021. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 25, 2021. ; https://doi.org/10.1101/2021.07.19.21260773 doi: medRxiv preprint . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 25, 2021. ; https://doi.org/10.1101/2021.07.19.21260773 doi: medRxiv preprint . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 25, 2021. ; https://doi.org/10.1101/2021.07.19.21260773 doi: medRxiv preprint . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 25, 2021. ; https://doi.org/10.1101/2021.07.19.21260773 doi: medRxiv preprint . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 25, 2021. ; https://doi.org/10.1101/2021.07.19.21260773 doi: medRxiv preprint . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 25, 2021. 

To fit the model to the clinical and/or wastewater surveillance data, we model the transmis-902 sion rate, β t as a piecewise linear function. We parsimoniously choose the times b 1 , b 2 , . . . ("break times") defining each segment by visual inspection of the time series (i.e., incidence 904 of new COVID-19 cases and/or hospitalizations for clinical surveillance; SARS-CoV-2 concentration for wastewater surveillance). Those times should correspond to changes in the 906 transmission dynamics. The value of the transmission rate at a break date, β(b i ) is fitted using an Approximate Bayesian Computation (ABC). We chose not to fit the break 908 times b i because the fitting algorithm would require a computation time that would not be practical. See Figure S1 .

The mean transit timeτ and the scaling factor ω are also fitted to data. For those parameters, the goal is primarily to allow for uncertainty rather than infer a posterior distribution 912 as they are essentially not identifiable. Finally, the hospitalization rate is also fitted to the hospitalization data, when available. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 25, 2021. ; https://doi.org/10.1101/2021.07. 19.21260773 doi: medRxiv preprint Over the study period (from early March 2020 to June 1st, 2021), we have about a dozen break times b i for each city to reflect the various interventions (e.g., lockdowns) or behaviour 916 (e.g., change in contact rate when schools re-opened in September 2020). Hence, the parameter space to explore by the ABC algorithm is relatively large. To avoid unpractical 918 computational times, we defined relative strong priors on all parameters, that is normal distributions with a mean close to the expected value (explored manually) and a relatively 

We assume the infectious period for symptomatic infections is 12 days on average [91, 92, 85, 82] and divide this period into n I = 6 sub-compartments I 1 , . . . , I 6 where infected 932 individuals will stay, on average, 2 days in each of them. Note that with this representation, the duration of infectiousness has an Erlang distribution [93] with shape n I (and mean 934 12 days). The parameter ψ k represents the relative infectiousness of sub-compartment I k . We assume infectiousness, that is the probability of transmission given contact, is Similarly, we assume a shorter infectious period for asymptomatic infections of 10 days on 940 average [94, 91] , divided into n A = 5 sub-compartments with an average stay of 2 days each.

Our model explicitly accounts for the temporal profile of respiratory shedding via the multi- We parameterize our model such that the SARS-CoV-2 viral kinetics reflect with levels 948 reported in the literature. The black line with points in Figure S2 shows the values used for respiratory (top panel) and faecal (bottom panel) shedding, and how they compare to 950 observational studies.

A-4 Effective reproduction number

As a first step, we establish the basic reproduction number, R 0 , for the model defined by equations 1a-1n. To derive R 0 , we follow the methodology presented in [42] .

Asymptomatic individuals are infectious for an average duration of 1/θ, and the ratio of their infectiousness compared to all the other infectious states (I and J) is ξ. Asymptomatic 956 incidence is a proportion α of the overall incidence. Hence, the contribution to the basic reproduction number from the asymptomatically infected individuals is 958

Infectious individuals that are symptomatic and that will recover without hospitalization (I) are infectious for an average duration of 1/ν. Their proportion of the overall incidence 

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 25, 2021. 

For the symptomatically infected persons that will require hospitalization (J), the same logic applies to the I sub-group, except that we need to take into account their relative 966 infectiousness compared to I, which is

Note that the denominator is simply n I thanks to the normalization defined in Equation A.1. The subgroup in state 968 J are hospitalized (h) and not asymptomatic (1 − α) so their contribution to the basic reproduction number is

We obtain the (overall) basic reproduction number by summing the respective contributions from all infectious epidemiological states

Finally, the effective reproduction number R t is simply defined as R t = St N R 0 which gives Equation 2 in the main text. Figure S3 : Impact of advection-dispersion-decay model (Eq. A.8). sampled RNA concentration (W samp ) may have different viral distribution compared to deposited density (W * ) due to delayed viral genetic materials resulting from hydrodynamical phenomenon in sewer system. and increase in-stream microorganism's concentration irrespective of new input from the 996 shedding source [106, 107] . Enveloped viruses, such as SARS-CoV-2, dissolve less in water and tends to attach to solids as a result of their hydrophobic envelope [39, 33] , and there-998 fore, settlement/resuspension may play a key role in transportation of the SARS-CoV-2 genetic materials in wastewater.

Here, we used a simple advection-dispersion-decay model to simulate the fate of SARS-CoV-2 RNA along their journey from shedding points to the sampling site. We assumed the 1002 deposited RNA concentration in the sewage system is a one-time pulse input per day and described the transfer process by a dispersed plug-flow model. As the plug concentration of 1004 viral RNA enters into the flow with velocity u, it gradually disperses along the longitudinal axis (flow direction) with dispersion coefficient D (m 2 /s) within the sewage pathway. The 1006 length from the shedding location to the sampling site is L. The total RNA mass arrives at the sampling point gradually over time, such that the daily pulse input concentration 1008 is delayed. Assuming a small deviation from plug flow (D/uL ≤ 0.01), we can use the analytical solution of the 1-dimensional axial dispersed plug flow differential equation [47, 1010 105] as a transfer function for viral RNA in wastewater. For low diffusion limit, the transfer function is approximately symmetrical and defined by a Gaussian distribution g(τ ), which 1012 represents the fraction of the deposited concentration at the sampling site τ days after its Defining the mean transit timeτ = L/u and its standard deviation σ = 2DL/u 3 , we can re-parametrize Equation A.6 based on the first two moments of the transit time:

In addition to delay, the genetic materials of SARS-CoV-2 degrades exponentially at a daily rate κ due to the complex environment of wastewater [46] . As a result, W (t), the where W * is the initial daily deposited concentration.

A-6 R t posterior estimates

The effective reproduction number R t is estimated by fitting the model to different data sources (see main text). We also estimate R t using the R library EpiEstim [57] on reported 1024 cases.

The function β t is modelled as piecewise-linear. As a result, R t from Eq. 2 is also a 1026 piecewise linear function. We interpolated R t with a polynomial curve (by smooth spline function in R) for Figure 4 . For validity purpose, we compared the interpolated and the 1028 piecewise linear function R t and checked the smoothed and actual curves are similar. See Figure S5 . 

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 25, 2021. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Figure S5 : The effective reproduction number and its 95% credible interval plotted for different sources (clin, ww and combined clinww) of fitting in wastewater sampling locations; Edmonton (EGB), Ottawa (OTW), Toronto Ashbridges Bay (TAB) and Toronto Humber (THU). Colours represent R t obtained from model and Eq. 2 (pink) and its interpolated smoothed spline (green).

saved on 2021-07-19 15:54:19-04:00

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 25, 2021. ; https://doi.org/10.1101/2021.07.19.21260773 doi: medRxiv preprint

Monitoring of regional drug abuse through wastewater-based epidemiology? A critical review (article)

Estimating community drug abuse by wastewater analysis

Cocaine in surface waters: a new evidence-based tool to monitor community drug abuse

The potential implications of reclaimed wastewater reuse for 584 irrigation on the agricultural environment: The knowns and unknowns of the fate of antibiotics and antibiotic resistant bacteria and resistance genes -A review

Urban wastewater treatment plants as hotspots for antibiotic resistant bacteria and genes spread into the environment: 588 a review

Abundances of tetracy-590 cline, sulphonamide and beta-lactam antibiotic resistance genes in conventional wastewater treatment plants (WWTPs) with different waste load

Wastewater-based epidemiology to assess human exposure to pyrethroid pesticides

Monitoring population exposure to pesticides based on liquid chromatography-tandem mass spectrometry measurement of their urinary metabolites in urban wastewater: 596 A novel biomonitoring approach

Sars-cov-2 598 surveillance employing sewage. towards a sentinel system

Emerging recombinant noroviruses identified by clinical and waste water screening

Surveillance of Noroviruses in Rio De Janeiro, Brazil: Occurrence of New GIV Genotype in Clinical and Wastewater Samples

Environmental surveillance for polioviruses in the Global Polio Eradication Initiative

Insights from a Systematic 612 Search for Information on Designs, Costs, and Effectiveness of Poliovirus Environmental Surveillance Systems

Epidemiology of the silent polio outbreak 616 in rahat, israel, based on modeling of environmental surveillance data

COVIDPoops19 Summary of Global SARS-CoV-2 Wastewater Monitoring Efforts by UC Merced Researchers. ArcGIS Online Dashboard

Presence of sarscoronavirus-2 rna in sewage and correlation with reported covid-19 prevalence in the early stage of the epidemic 622 in the netherlands

First confirmed detection of SARS-CoV-2 in untreated wastewater in Australia: A proof of 626 concept for the wastewater surveillance of COVID-19 in the community

Evaluation of lockdown effect on SARS-CoV-2 dynamics through viral genome quantification in waste water

Measurement of SARS-CoV-2 RNA in wastewater tracks community infection dynamics

First detection of SARS-CoV-2 in untreated wastewaters in Italy

Tracking COVID-19 with wastewater

SARS-CoV-2 RNA in wastewater anticipated COVID-19 occurrence in a low prevalence area

Quantitative analysis of SARS-CoV-2 RNA from wastewater solids in communities with low COVID-19 incidence and prevalence

Detection of SARS-CoV-2 in wastewater in Japan during a COVID-19 outbreak

Implementing building-level SARS-CoV-2 wastewater surveillance on a university campus

University of Arizona used wastewater testing to detect cases of coronavirus in a dorm

University of Guelph testing campus residences' wastewater to detect COVID-19

Sci Total Environ Catching a resurgence: Increase in SARS-CoV-2 viral RNA identified in wastewater 48 h before COVID-19 clinical tests and 96 h before hospitalizations

Welfare the Environment, Ministry of Health, and Sport

Amsterdam: National Institute for Public Health and the Environment

Wastewater COVID-19 surveillance

Ontario Agency for Health Protection and Promotion, Wastewater surveillance of 666 COVID-19

World Health Organization, Status of environmental surveillance for SARS-CoV-2 virus: scientific brief. 668 World Health Organization

Sars-cov-2 from faeces to wastewater treatment: What do we know? a review

Uncertainties in estimating SARS-CoV-2 prevalence by wastewater-based epidemiology

Early warning of COVID-19 via wastewater-based epidemiology: potential and bottlenecks

Researchers looking for clues to the COVID-19 pandemic in city sewers. Global News

Shedding of sars-cov-2 in feces and urine and its potential role in person-to-person transmission and the environment-based spread of covid-19

Differences of severe acute respiratory syndrome coronavirus 2 shedding duration in sputum and 684 nasopharyngeal swab specimens among adult inpatients with coronavirus disease

Survival of Coronaviruses in Water and Wastewater

Sci Total EnvironSARS-CoV-2 in wastewater: State of the knowledge and research needs

J Environ Chem EngSewage analysis as a tool for 692 the COVID-19 pandemic response and management: the urgent need for optimised protocols for SARS-CoV-2 detection and quantification

Infectious Diseases of Humans -Dynamics and Control

Appropriate models for the management of infectious diseases

Temporal dynamics in viral shedding and transmissibility of COVID-19

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia

Decay of sars-cov-2 and surrogate murine hepatitis virus rna in untreated wastewater to inform application in wastewater-based 712 epidemiology

Chapter eight -residence time distributions in flow reactors

Wastewater collection and treatment, Robert O

City of Toronto, Ashbridges Bay wastewater treatment plant annual report of 2020

City of Toronto, Humber wastewater treatment plant annual report of 2020

City of Toronto, Highland Creek wastewater treatment plant annual report of 2020. Online

Census of Canada via Toronto Public Health

Covid-19 public seroprevalence report

Approximate Bayesian Computation in Population Genetics

Reproduction number (R) and growth rate (r) of the COVID-19 epidemic in the UK: methods of estimation, data sources, 728 causes of heterogeneity, and use as a guide in policy formulation

ScienceInferring the effectiveness of government interventions 732 against COVID-19

A New Framework and Software to Estimate Time-734

Varying Reproduction Numbers During Epidemics

Reproducibility and sensitivity 738 of 36 methods to quantify the sars-cov-2 genetic signal in raw wastewater: findings from an interlaboratory methods evaluation in the us

Persistence of sars-cov-2 in water and wastewater

A review on presence, survival, disinfection/removal methods of 744 coronavirus in wastewater and progress of wastewater-based epidemiology

Environ IntFuture perspectives of wastewater-based epidemiology: Monitoring infectious disease spread and resistance to the community level

Wastewater-based estimation of the effective reproductive number of sars-cov-2. medRxiv

medRxivMetrics to relate COVID-19 wastewater data to clinical testing dynamics. medRxiv

Sci Total EnvironData-driven estimation of COVID-19 community prevalence through wastewater-758 based epidemiology

Diagnostic serial interval as a novel indicator for 760 contact tracing effectiveness exemplified with the sars-cov-2/covid-19 outbreak in south korea

Early and ongoing importations of sars-cov-2 in canada. medRxiv

S-Variant SARS-CoV-2 Lineage B1.1.7 Is Associated With Significantly Higher Viral Load in Samples Tested by TaqPath Polymerase Chain Reaction

Densely sampled viral trajectories for sars-cov-2 variants alpha

Avoidable errors in the modelling of outbreaks of emerging pathogens, with special reference to Ebola

Fitting mechanistic epidemic models to data: A com-778 parison of simple Markov chain Monte Carlo approaches

medRxivCOVID-19 Wastewater Epidemiology: A Model to Estimate Infected Popula-782 tions. medRxiv

AModeling environmentally mediated rotavirus transmission: The role of temperature and hydrologic factors

Water ResRapid screening for 788 SARS-CoV-2 variants of concern in clinical and environmental samples using nested RT-PCR assays targeting key mutations of the spike protein

A pan-European study of SARS-CoV-2 variants in wastewater under the EU 792 Sewage Sentinel System. medRxiv

Detection of 796 sars-cov-2 variants in switzerland by genomic analysis of wastewater samples

Diagnostic performance of a SARS-CoV-2 rapid antigen test in a large, Norwegian cohort

Sars-cov-2 load does not predict transmissibility in college students. medRxiv

Prolonged SARS-CoV-2 cell culture replication in respiratory samples from patients with severe COVID-19

Infectivity of asymptomatic 808 versus symptomatic COVID-19

Comparison 812 of Upper Respiratory Viral Load Distributions in Asymptomatic and Symptomatic Children Diagnosed with SARS-CoV-2 Infection in Pediatric Hospital Testing Programs

Sars-cov-2 viral dynamics in acute infections. medRxiv

Almea Matanock, and Household Transmission Study Team. Persistent 822 SARS-CoV-2 RNA Shedding without Evidence of Infectiousness: A Cohort Study of Individuals with COVID-19

Viral kinetics of sars-cov-2 over the preclinical, clinical, and postclinical period

Modeling sars-cov-2 832 viral kinetics and association with mortality in hospitalized patients from the french covid cohort

Cae-836 seele, and Guillaume Poliquin. Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic Samples

Time between Symptom Onset, Hospitalisation and Recovery or Death: Statistical Analysis of Belgian

Faecal shedding models for sars-cov-2 rna amongst hospitalised patients and 846 implications for wastewater-based epidemiology. medRxiv

Estimating the asymptomatic proportion of coronavirus 848 disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship

Estimation of the asymptomatic ratio of novel coronavirus infections 852 (COVID-19)

Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis

Sars-cov-2, sars-cov, and mers-cov viral load dynamics, duration of viral shedding, and infectiousness: a systematic review 858 and meta-analysis

Didier Raoult, 860 and Bernard La Scola. Correlation Between 3790 Quantitative Polymerase Chain Reaction-Positives Samples and Positive Cell Cultures, Including 1941 Severe Acute Respiratory Syndrome Coronavirus 2 Isolates. Clinical 862 Infectious Diseases

On the spread of a disease with gamma distributed latent and infectious 864 periods

Spatial and temporal dynamics of sars-cov-2 866 in covid-19 patients: A systematic review and meta-analysis

Sars-cov-2 viral load peaks prior to symptom onset: a systematic review and individual-pooled analysis of coronavirus viral load from 66 studies. medRxiv

SARS-CoV-2 viral load 872 kinetics in symptomatic children, adolescents and adults

Duration of sars-cov-2 viral shedding in faeces as a 874 parameter for wastewater-based epidemiology: Re-analysis of patient data using a shedding dynamics model

Modeling the transport and distribution of fecal coliform in a tidal estuary

Assessment of sources of human pathogens and fecal contamination in a florida freshwater lake

Transport and deposition of 882 sediment-associated escherichia coli in natural streams

Hydrograph-based approach to modeling bacterial fate and transport in 884 rivers

Modeling sediment impact on the transport of fecal bacteria

Quil-888 liam, and Daniel R. Shelton. Modeling fate and transport of fecally-derived microorganisms at the watershed scale: State of the science and future opportunities

Importance of interactions between the water column and the sediment for microbial concentrations in streams

The Dispersion Model

Generation of fecal and total coliform surges by stream flow manipulation 894 in the absence of normal hydrometeorological stimuli

Faecal contamination over flood events in a pastoral agricultural stream in New Zealand

Appendix 900